DI Feinstein

1.7k total citations · 1 hit paper
20 papers, 1.3k citations indexed

About

DI Feinstein is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, DI Feinstein has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 9 papers in Hematology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in DI Feinstein's work include Lymphoma Diagnosis and Treatment (7 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). DI Feinstein is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). DI Feinstein collaborates with scholars based in United States. DI Feinstein's co-authors include Samuel I. Rapaport, AM Levine, RJ Lukes, CK Kasper, SJ Forman, A. M. Levine, SJ Forman, Alan Lichtenstein, CR Taylor and SI Rapaport and has published in prestigious journals such as Blood, PubMed and Medical Entomology and Zoology.

In The Last Decade

DI Feinstein

19 papers receiving 1.1k citations

Hit Papers

Acquired inhibitors of blood coagulation. 1972 2026 1990 2008 1972 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Acquired inhibitors of blood coagulation.
    1972 390 citations DI Feinstein, Samuel I. Rapaport PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DI Feinstein United States 15 660 343 313 253 206 20 1.3k
Donald I. Feinstein United States 21 656 1.0× 351 1.0× 162 0.5× 247 1.0× 158 0.8× 49 1.4k
Sultan Y France 14 918 1.4× 238 0.7× 286 0.9× 66 0.3× 121 0.6× 67 1.3k
Megan O. Nakashima United States 18 371 0.6× 371 1.1× 114 0.4× 391 1.5× 259 1.3× 55 1.5k
Javier Batlle Spain 23 1.3k 2.0× 327 1.0× 183 0.6× 59 0.2× 144 0.7× 57 1.6k
Maria Tiziana Bertero Italy 17 401 0.6× 306 0.9× 560 1.8× 100 0.4× 199 1.0× 43 1.3k
Görgün Akpek United States 25 1.1k 1.7× 399 1.2× 159 0.5× 296 1.2× 385 1.9× 65 2.0k
G. Brehm Germany 13 1.1k 1.7× 266 0.8× 89 0.3× 99 0.4× 841 4.1× 23 1.9k
J. Th. M. de Wolf Netherlands 22 1.0k 1.6× 324 0.9× 65 0.2× 114 0.5× 215 1.0× 52 1.7k
L Gugliotta Italy 21 957 1.4× 622 1.8× 179 0.6× 77 0.3× 363 1.8× 66 1.4k
Elena Oldani Italy 18 570 0.9× 236 0.7× 74 0.2× 332 1.3× 181 0.9× 41 1.2k

Countries citing papers authored by DI Feinstein

Since Specialization
Citations

This map shows the geographic impact of DI Feinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DI Feinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DI Feinstein more than expected).

Fields of papers citing papers by DI Feinstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DI Feinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DI Feinstein. The network helps show where DI Feinstein may publish in the future.

Co-authorship network of co-authors of DI Feinstein

This figure shows the co-authorship network connecting the top 25 collaborators of DI Feinstein. A scholar is included among the top collaborators of DI Feinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DI Feinstein. DI Feinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Levine, AM, et al.. (1983). Successful therapy of convoluted T-lymphoblastic lymphoma in the adult. Blood. 61(1). 92–98. 57 indexed citations
3.
Levine, AM, et al.. (1983). Successful therapy of convoluted T-lymphoblastic lymphoma in the adult. Blood. 61(1). 92–98. 1 indexed citations
4.
Feinstein, DI. (1982). Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood. 60(2). 284–287. 103 indexed citations
5.
Feinstein, DI. (1982). Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood. 60(2). 284–287. 131 indexed citations
6.
Levine, AM, et al.. (1981). Immunoblastic sarcoma of T-cell versus B-cell origin: I. Clinical features. Blood. 58(1). 52–61. 72 indexed citations
7.
Levine, A. M., et al.. (1981). Immunoblastic sarcoma of T-cell versus B-cell origin: I. Clinical features. Blood. 58(1). 52–61. 90 indexed citations
8.
Levine, AM, et al.. (1980). Positive Coombs test in Hodgkin's disease: significance and implications. Blood. 55(4). 607–611. 25 indexed citations
9.
Levine, AM, Patrick Thornton, SJ Forman, et al.. (1980). Positive Coombs test in Hodgkin's disease: significance and implications. Blood. 55(4). 607–611. 28 indexed citations
10.
Feinstein, DI, et al.. (1979). Quantitative anisocytosis as a discriminant between iron deficiency and thalassemia minor. Blood. 53(2). 288–293. 102 indexed citations
11.
Feinstein, DI, et al.. (1979). Quantitative anisocytosis as a discriminant between iron deficiency and thalassemia minor. Blood. 53(2). 288–293. 14 indexed citations
12.
Levine, AM, et al.. (1979). Use and efficacy of pneumococcal vaccine in patients with Hodgkin disease. Blood. 54(5). 1171–1175. 32 indexed citations
13.
Kasper, CK, et al.. (1977). Detection of factor VIII inhibitors with the partial thromboplastin time. Blood. 49(5). 793–797. 60 indexed citations
14.
Feinstein, DI, et al.. (1977). Relationship of contact activation cofactor (CAC) procoagulant activity to kininogen. Blood. 49(6). 935–945. 18 indexed citations
15.
Feinstein, DI, et al.. (1977). Relationship of contact activation cofactor (CAC) procoagulant activity to kininogen. Blood. 49(6). 935–945. 2 indexed citations
16.
Kasper, CK, et al.. (1977). Detection of factor VIII inhibitors with the partial thromboplastin time. Blood. 49(5). 793–797. 5 indexed citations
17.
Feinstein, DI, et al.. (1976). Factor XI activity and factor XI antigen in homozygous and heterozygous factor XI deficiency. Blood. 48(2). 165–174. 1 indexed citations
18.
Feinstein, DI, et al.. (1976). Factor XI activity and factor XI antigen in homozygous and heterozygous factor XI deficiency. Blood. 48(2). 165–174. 35 indexed citations
19.
Feinstein, DI & Samuel I. Rapaport. (1972). Acquired inhibitors of blood coagulation.. PubMed. 1. 75–95. 390 indexed citations breakdown →
20.
Feinstein, DI. (1972). Acquired inhibitors of blood cagulation. Medical Entomology and Zoology. 1. 75–95. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald I. Feinstein Breakdown of academic impact, for papers by Sultan Y Breakdown of academic impact, for papers by Megan O. Nakashima Breakdown of academic impact, for papers by Javier Batlle Breakdown of academic impact, for papers by Maria Tiziana Bertero Breakdown of academic impact, for papers by Görgün Akpek Breakdown of academic impact, for papers by G. Brehm Breakdown of academic impact, for papers by J. Th. M. de Wolf Breakdown of academic impact, for papers by L Gugliotta Breakdown of academic impact, for papers by Elena Oldani
Rankless by CCL
2026